| (+)-alpha-tocopherol | increases phosphorylation | ISO | RGD:736023 | 6480464 | alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein | CTD | PMID:20686688 |
| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:736023 | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:20686688 |
| (+)-alpha-viniferin | multiple interactions | ISO | RGD:736024 | 6480464 | alpha-viniferin inhibits the reaction [MAPK9 protein results in increased phosphorylation of and results in increased activity of STAT1 protein] | CTD | PMID:20424383 |
| (-)-anisomycin | multiple interactions | ISO | RGD:736024 | 6480464 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15772366 |
| (-)-anisomycin | increases phosphorylation | ISO | RGD:736024 | 6480464 | Anisomycin results in increased phosphorylation of MAPK9 protein | CTD | PMID:16038797 PMID:15772366 |
| (-)-anisomycin | increases phosphorylation | ISO | RGD:736024 | 6480464 | Anisomycin results in increased phosphorylation of MAPK9 protein | CTD | PMID:15772366 PMID:16038797 |
| (-)-anisomycin | increases phosphorylation | ISO | RGD:736023 | 6480464 | Anisomycin results in increased phosphorylation of MAPK9 protein | CTD | PMID:12967334 |
| (-)-citrinin | increases phosphorylation | ISO | RGD:736023 | 6480464 | Citrinin results in increased phosphorylation of MAPK9 protein | CTD | PMID:19361540 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:736023 | 6480464 | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19944065 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:736024 | 6480464 | MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Norepinephrine] | CTD | PMID:16949803 |
| (R)-noradrenaline | affects response to substance | ISO | RGD:736024 | 6480464 | MAPK9 protein affects the susceptibility to Norepinephrine | CTD | PMID:16949803 |
| (S)-colchicine | increases phosphorylation | ISO | RGD:736023 | 6480464 | Colchicine results in increased phosphorylation of MAPK9 protein | CTD | PMID:12221076 |
| (S)-colchicine | multiple interactions | ISO | RGD:736023 | 6480464 | TP53 protein affects the reaction [Colchicine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:12221076 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | RGD:736023 | 6480464 | APOE gene polymorphism affects the reaction [Dihydrotestosterone affects the phosphorylation of MAPK9 protein] | CTD | PMID:17395708 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736024 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAPK9 mRNA | CTD | PMID:21570461 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:736024 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein | CTD | PMID:22427801 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:736024 | 6480464 | D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein]; more ... | CTD | PMID:22427801 |
| 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid | multiple interactions | ISO | RGD:736024 | 6480464 | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein] | CTD | PMID:19815690 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:736023 | 6480464 | [IL24 protein co-treated with Fenretinide] results in increased phosphorylation of MAPK9 protein | CTD | PMID:15580305 |
| 4-phenylbutyric acid | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21147958 |
| 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of MAPK9 mRNA | CTD | PMID:18077114 |
| acetaldehyde | increases phosphorylation | ISO | RGD:736023 | 6480464 | Acetaldehyde results in increased phosphorylation of MAPK9 protein | CTD | PMID:19110045 |
| acetaldehyde | multiple interactions | ISO | RGD:736023 | 6480464 | Hesperidin inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19110045 |
| acetaldehyde | increases activity | EXP | | 6480464 | Acetaldehyde results in increased activity of MAPK9 protein | CTD | PMID:10733585 |
| afimoxifene | decreases response to substance | ISO | RGD:736023 | 6480464 | MAPK9 results in decreased susceptibility to 4-hydroxytamoxifen; more ... | CTD | PMID:21233418 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin results in decreased phosphorylation of and results in decreased activity of MAPK9 protein | CTD | PMID:16043492 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:736024 | 6480464 | Tretinoin results in decreased expression of MAPK9 mRNA | CTD | PMID:22498432 |
| aluminium trichloride | multiple interactions | EXP | | 6480464 | aluminum chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein; more ... | CTD | PMID:12865155 |
| amidotrizoic acid | increases phosphorylation | ISO | RGD:736023 | 6480464 | Diatrizoate results in increased phosphorylation of MAPK9 protein | CTD | PMID:21036957 |
| amiloride | multiple interactions | ISO | RGD:736024 | 6480464 | Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein] | CTD | PMID:19815690 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MAPK9 mRNA | CTD | PMID:16483693 |
| aniline | increases phosphorylation | EXP | | 6480464 | aniline results in increased phosphorylation of MAPK9 protein | CTD | PMID:16169568 PMID:18420242 |
| aniline | increases phosphorylation | EXP | | 6480464 | aniline results in increased phosphorylation of MAPK9 protein | CTD | PMID:18420242 PMID:16169568 |
| apocynin | multiple interactions | ISO | RGD:736023 | 6480464 | acetovanillone inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21391979 |
| arsenic atom | multiple interactions | EXP | | 6480464 | Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK9 protein; more ... | CTD | PMID:11756236 |
| arsenic atom | multiple interactions | ISO | RGD:736023 | 6480464 | Arsenic results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:14633691 |
| arsenic atom | multiple interactions | EXP | | 6480464 | O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate promotes the reaction [Arsenic results in increased phosphorylation of and results in increased activity of MAPK9 protein]; more ... | CTD | PMID:15210857 |
| arsenic trichloride | increases phosphorylation | ISO | RGD:736023 | 6480464 | arsenic trichloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:22696236 |
| arsenic trichloride | multiple interactions | ISO | RGD:736023 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenic trichloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22696236 |
| arsenic trichloride | multiple interactions | ISO | RGD:736024 | 6480464 | MAPK9 gene mutant form inhibits the reaction [arsenic trichloride results in increased phosphorylation of AKT1 protein]; more ... | CTD | PMID:22696236 |
| arsenite(3-) | increases phosphorylation | ISO | RGD:736024 | 6480464 | arsenite results in increased phosphorylation of MAPK9 protein | CTD | PMID:19808956 |
| arsenite(3-) | multiple interactions | ISO | RGD:736023 | 6480464 | [arsenite results in increased activity of PRKDC protein] which results in increased phosphorylation of and results in increased activity of MAPK9 protein; more ... | CTD | PMID:22366412 |
| arsenite(3-) | multiple interactions | ISO | RGD:736024 | 6480464 | MAP3K8 protein affects the reaction [arsenite results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19808956 |
| benzene | multiple interactions | ISO | RGD:736024 | 6480464 | TRP53 protein inhibits the reaction [Benzene results in increased expression of MAPK9] | CTD | PMID:15935813 |
| benzo[a]pyrene | increases expression | ISO | RGD:736024 | 6480464 | Benzo(a)pyrene results in increased expression of MAPK9 mRNA | CTD | PMID:19770486 PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:736024 | 6480464 | Benzo(a)pyrene results in increased expression of MAPK9 mRNA | CTD | PMID:21715664 PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736024 | 6480464 | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK9 protein] | CTD | PMID:18321868 |
| benzo[a]pyrene | increases phosphorylation | ISO | RGD:736024 | 6480464 | Benzo(a)pyrene results in increased phosphorylation of MAPK9 protein | CTD | PMID:18321868 |
| benzo[a]pyrene | increases expression | ISO | RGD:736024 | 6480464 | Benzo(a)pyrene results in increased expression of MAPK9 mRNA | CTD | PMID:21715664 |
| beta-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19760616 |
| beta-hexachlorocyclohexane | increases phosphorylation | EXP | | 6480464 | beta-hexachlorocyclohexane results in increased phosphorylation of MAPK9 protein | CTD | PMID:19760616 |
| bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | RGD:736024 | 6480464 | Mustard Gas results in increased phosphorylation of MAPK9 protein | CTD | PMID:18200059 |
| bisphenol A | increases phosphorylation | EXP | | 6480464 | bisphenol A results in increased phosphorylation of MAPK9 protein | CTD | PMID:20096755 |
| bufalin | decreases activity | ISO | RGD:736023 | 6480464 | bufalin results in decreased activity of MAPK9 protein | CTD | PMID:21922632 |
| cadmium atom | multiple interactions | ISO | RGD:736024 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:15254339 |
| cadmium atom | affects response to substance | ISO | RGD:736023 | 6480464 | MAPK9 affects the susceptibility to Cadmium | CTD | PMID:10874022 |
| cadmium atom | affects response to substance | EXP | | 6480464 | MAPK9 protein affects the susceptibility to Cadmium | CTD | PMID:16516943 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Cadmium results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:16568437 |
| cadmium atom | multiple interactions | ISO | RGD:736024 | 6480464 | [MT1 protein co-treated with MT2 protein] inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] | CTD | PMID:16568437 |
| cadmium atom | multiple interactions | ISO | RGD:736024 | 6480464 | Cadmium results in increased phosphorylation of and results in increased activity of MAPK9 protein; more ... | CTD | PMID:16728380 |
| cadmium atom | increases phosphorylation | ISO | RGD:736024 | 6480464 | Cadmium results in increased phosphorylation of MAPK9 protein | CTD | PMID:15212812 PMID:15254339 |
| cadmium dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein; more ... | CTD | PMID:16728380 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:736024 | 6480464 | Cadmium Chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:11958953 PMID:19887573 |
| cadmium dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:15081267 more ... |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:15618353 PMID:21544200 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:736023 | 6480464 | Cadmium Chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:10874044 |
| cadmium dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | LL Z1640-2 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:15081267 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:736024 | 6480464 | Cadmium Chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:19887573 PMID:11958953 |
| cadmium dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | MT1 affects the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:11958953 |
| cadmium dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:16728380 more ... |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | N(6),N(6)-dimethyladenine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:15618353 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of MAPK9 promoter | CTD | PMID:22457795 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein; more ... | CTD | PMID:21544200 |
| cadmium dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | MAPK9 mutant form inhibits the reaction [Cadmium Chloride results in increased expression of HSPA1A protein] | CTD | PMID:18348256 |
| cadmium dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:21544200 PMID:16728380 |
| cadmium dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein]; more ... | CTD | PMID:21544200 |
| cadmium dichloride | multiple interactions | ISO | RGD:736023 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein]; more ... | CTD | PMID:21544200 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein; more ... | CTD | PMID:20829427 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:736024 | 6480464 | Cadmium Chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:19887573 |
| cadmium dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:19887573 |
| cadmium dichloride | multiple interactions | ISO | RGD:736023 | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA | CTD | PMID:12634122 |
| cadmium sulfate | multiple interactions | ISO | RGD:736024 | 6480464 | cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK9 protein; more ... | CTD | PMID:14687664 |
| camptothecin | increases phosphorylation | ISO | RGD:736023 | 6480464 | Camptothecin results in increased phosphorylation of MAPK9 protein | CTD | PMID:15585644 |
| capsaicin | multiple interactions | ISO | RGD:736023 | 6480464 | Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21462327 |
| capsaicin | increases activity | ISO | RGD:736023 | 6480464 | Capsaicin results in increased activity of MAPK9 protein | CTD | PMID:9580328 |
| capsaicin | increases phosphorylation | ISO | RGD:736023 | 6480464 | Capsaicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:20619260 |
| capsaicin | multiple interactions | ISO | RGD:736023 | 6480464 | Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21745629 |
| choline | multiple interactions | ISO | RGD:736024 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAPK9 gene | CTD | PMID:20938992 |
| choline | multiple interactions | ISO | RGD:736024 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased phosphorylation of MAPK9 protein; more ... | CTD | PMID:23038002 |
| chromium(6+) | multiple interactions | ISO | RGD:736024 | 6480464 | Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:19654923 |
| chromium(6+) | increases phosphorylation | ISO | RGD:736024 | 6480464 | chromium hexavalent ion results in increased phosphorylation of MAPK9 protein | CTD | PMID:19654923 PMID:19895865 |
| chromium(6+) | increases phosphorylation | ISO | RGD:736024 | 6480464 | chromium hexavalent ion results in increased phosphorylation of MAPK9 protein | CTD | PMID:19895865 |
| chromium(6+) | increases expression | ISO | RGD:736024 | 6480464 | chromium hexavalent ion results in increased expression of MAPK9 protein | CTD | PMID:19895865 |
| chromium(6+) | multiple interactions | ISO | RGD:736024 | 6480464 | [Arsenates co-treated with chromium hexavalent ion] results in increased expression of MAPK9 protein; more ... | CTD | PMID:19895865 |
| chromium(6+) | increases phosphorylation | ISO | RGD:736023 | 6480464 | chromium hexavalent ion results in increased phosphorylation of MAPK9 protein | CTD | PMID:17045426 |
| chromium(6+) | increases phosphorylation | ISO | RGD:736024 | 6480464 | chromium hexavalent ion results in increased phosphorylation of MAPK9 protein | CTD | PMID:19895865 PMID:19654923 |
| cisplatin | multiple interactions | ISO | RGD:736023 | 6480464 | [Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of MAPK9 protein | CTD | PMID:21214929 |
| cisplatin | multiple interactions | EXP | | 6480464 | N-Acetylcysteinamide inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15147517 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of MAPK9 protein | CTD | PMID:15147517 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPK9 mRNA | CTD | PMID:17602206 |
| clozapine | affects expression | EXP | | 6480464 | Clozapine affects the expression of MAPK9 mRNA | CTD | PMID:15860345 |
| cobalt dichloride | increases phosphorylation | ISO | RGD:736023 | 6480464 | cobaltous chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:19101624 |
| copper atom | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:22085843 |
| copper(0) | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:22085843 |
| copper(2+) sulfate | decreases expression | ISO | RGD:736023 | 6480464 | Copper Sulfate results in decreased expression of MAPK9 mRNA | CTD | PMID:19549813 |
| curcumin | multiple interactions | ISO | RGD:736024 | 6480464 | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK9 protein] | CTD | PMID:18321868 |
| curcumin | decreases phosphorylation | EXP | | 6480464 | Curcumin results in decreased phosphorylation of MAPK9 protein | CTD | PMID:18332871 |
| curcumin | increases phosphorylation | ISO | RGD:736023 | 6480464 | Curcumin results in increased phosphorylation of MAPK9 protein | CTD | PMID:18316600 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin results in decreased phosphorylation of and results in decreased activity of MAPK9 protein | CTD | PMID:17372590 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:11981161 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | Cyclophosphamide results in increased phosphorylation of and results in increased activity of MAPK9 protein; more ... | CTD | PMID:19996110 |
| cyclosporin A | increases expression | ISO | RGD:736023 | 6480464 | Cyclosporine results in increased expression of MAPK9 mRNA | CTD | PMID:20106945 |
| D-glucose | increases phosphorylation | EXP | | 6480464 | Glucose results in increased phosphorylation of MAPK9 protein | CTD | PMID:19861503 |
| DDT | decreases phosphorylation | ISO | RGD:736023 | 6480464 | DDT results in decreased phosphorylation of MAPK9 protein | CTD | PMID:14604893 |
| desferrioxamine B | increases phosphorylation | ISO | RGD:736023 | 6480464 | Deferoxamine results in increased phosphorylation of MAPK9 protein | CTD | PMID:20368581 |
| desferrioxamine B | multiple interactions | ISO | RGD:736023 | 6480464 | Deferoxamine inhibits the reaction [Plant Extracts results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20206247 |
| diarsenic trioxide | increases activity | ISO | RGD:736023 | 6480464 | arsenic trioxide results in increased activity of MAPK9 protein | CTD | PMID:12296996 |
| diarsenic trioxide | increases phosphorylation | ISO | RGD:736023 | 6480464 | arsenic trioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:18412143 |
| diarsenic trioxide | multiple interactions | ISO | RGD:736023 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:18412143 |
| diarsenic trioxide | increases expression | ISO | RGD:736023 | 6480464 | arsenic trioxide results in increased expression of MAPK9 protein | CTD | PMID:17374990 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21145380 |
| diarsenic trioxide | increases phosphorylation | EXP | | 6480464 | arsenic trioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:21145380 |
| diarsenic trioxide | increases response to substance | ISO | RGD:736024 | 6480464 | MAPK9 protein results in increased susceptibility to arsenic trioxide; more ... | CTD | PMID:16818652 |
| diarsenic trioxide | increases phosphorylation | ISO | RGD:736024 | 6480464 | arsenic trioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:15688020 |
| diarsenic trioxide | increases response to substance | ISO | RGD:736023 | 6480464 | MAPK9 results in increased susceptibility to arsenic trioxide | CTD | PMID:20799280 |
| diarsenic trioxide | multiple interactions | ISO | RGD:736023 | 6480464 | indole-5-carboxamide promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK9 protein]; more ... | CTD | PMID:16818652 |
| diarsenic trioxide | multiple interactions | ISO | RGD:736023 | 6480464 | [IL24 protein co-treated with arsenic trioxide] results in increased phosphorylation of MAPK9 protein | CTD | PMID:15580305 |
| diarsenic trioxide | multiple interactions | ISO | RGD:736023 | 6480464 | [bortezomib co-treated with arsenic trioxide] affects the expression of MAPK9 protein | CTD | PMID:18718063 |
| diarsenic trioxide | multiple interactions | ISO | RGD:736023 | 6480464 | arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK9 protein; more ... | CTD | PMID:20799280 |
| dichromium trioxide | multiple interactions | ISO | RGD:736023 | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA | CTD | PMID:12634122 |
| dioxygen | multiple interactions | ISO | RGD:736023 | 6480464 | MAPK9 protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 protein] | CTD | PMID:19196431 |
| dioxygen | multiple interactions | ISO | RGD:736023 | 6480464 | TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20812253 |
| dioxygen | increases phosphorylation | EXP | | 6480464 | Oxygen results in increased phosphorylation of MAPK9 protein | CTD | PMID:20812253 |
| dioxygen | increases phosphorylation | ISO | RGD:736023 | 6480464 | Oxygen deficiency results in increased phosphorylation of MAPK9 protein | CTD | PMID:19196431 |
| diquat | multiple interactions | ISO | RGD:736024 | 6480464 | PROP1 protein affects the reaction [Diquat affects the phosphorylation of MAPK9 protein] | CTD | PMID:20826540 |
| disodium selenite | multiple interactions | ISO | RGD:736023 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:18728404 |
| disodium selenite | affects expression | EXP | | 6480464 | Sodium Selenite affects the expression of MAPK9 | CTD | PMID:18209489 |
| disodium selenite | increases expression | ISO | RGD:736023 | 6480464 | Sodium Selenite results in increased expression of MAPK9 protein | CTD | PMID:18728404 |
| dobutamine | multiple interactions | EXP | | 6480464 | [Dobutamine co-treated with ICI 118551] results in increased activity of MAPK9 protein | CTD | PMID:19719783 |
| donepezil hydrochloride | multiple interactions | EXP | | 6480464 | donepezil inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of MAPK9 protein] | CTD | PMID:19345205 |
| doxorubicin | multiple interactions | ISO | RGD:736023 | 6480464 | [Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of MAPK9 protein | CTD | PMID:21214929 |
| doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:16213474 PMID:17384285 |
| doxorubicin | increases phosphorylation | ISO | RGD:736023 | 6480464 | Doxorubicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:15585644 PMID:15557793 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK9 protein; more ... | CTD | PMID:16687611 |
| doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:17384285 PMID:16213474 |
| doxorubicin | multiple interactions | ISO | RGD:736023 | 6480464 | RBL2 protein inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15585644 |
| doxorubicin | increases phosphorylation | ISO | RGD:736023 | 6480464 | Doxorubicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:15557793 PMID:15585644 |
| doxorubicin | multiple interactions | ISO | RGD:736023 | 6480464 | Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:15494689 |
| doxorubicin | multiple interactions | ISO | RGD:736023 | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:15557793 |
| elemental selenium | multiple interactions | ISO | RGD:736023 | 6480464 | [Selenium co-treated with SB 203580] results in decreased expression of MAPK9 protein | CTD | PMID:18583539 |
| elemental selenium | decreases expression | ISO | RGD:736023 | 6480464 | Selenium results in decreased expression of MAPK9 protein modified form | CTD | PMID:18583539 |
| emetine | multiple interactions | ISO | RGD:736024 | 6480464 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Emetine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15772366 |
| emetine | increases phosphorylation | ISO | RGD:736024 | 6480464 | Emetine results in increased phosphorylation of MAPK9 protein | CTD | PMID:15772366 |
| enalapril | increases expression | EXP | | 6480464 | Enalapril results in increased expression of MAPK9 protein; more ... | CTD | PMID:15531746 |
| enalapril | increases phosphorylation | EXP | | 6480464 | Enalapril results in increased phosphorylation of MAPK9 protein | CTD | PMID:15531746 |
| esculetin | multiple interactions | ISO | RGD:736023 | 6480464 | [esculetin co-treated with Paclitaxel] results in increased expression of MAPK9 protein | CTD | PMID:16051289 |
| esculetin | increases expression | ISO | RGD:736023 | 6480464 | esculetin results in increased expression of MAPK9 protein | CTD | PMID:16051289 |
| ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of MAPK9 mRNA | CTD | PMID:11772933 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | EXP | | 6480464 | Egtazic Acid inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:11981161 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:736024 | 6480464 | Egtazic Acid inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15254339 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:736024 | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | EXP | | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:736023 | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
| folic acid | multiple interactions | ISO | RGD:736024 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAPK9 gene | CTD | PMID:20938992 |
| gallic acid | multiple interactions | ISO | RGD:736023 | 6480464 | Gallic Acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21420233 |
| glucose | increases phosphorylation | EXP | | 6480464 | Glucose results in increased phosphorylation of MAPK9 protein | CTD | PMID:19861503 |
| glutathione | multiple interactions | ISO | RGD:736024 | 6480464 | Glutathione inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20423716 |
| haloperidol | affects expression | EXP | | 6480464 | Haloperidol affects the expression of MAPK9 mRNA | CTD | PMID:15860345 |
| hemin | multiple interactions | EXP | | 6480464 | chromium mesoporphyrin inhibits the reaction [Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA]] | CTD | PMID:19190261 |
| hesperidin | multiple interactions | ISO | RGD:736023 | 6480464 | Hesperidin inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19110045 |
| hydrogen peroxide | decreases expression | ISO | RGD:736023 | 6480464 | Hydrogen Peroxide results in decreased expression of MAPK9 mRNA | CTD | PMID:12419474 |
| hydrogen peroxide | increases activity | ISO | RGD:736024 | 6480464 | Hydrogen Peroxide results in increased activity of MAPK9 protein | CTD | PMID:11181820 PMID:14975446 |
| hydrogen peroxide | increases phosphorylation | ISO | RGD:736023 | 6480464 | Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:20302854 PMID:15795422 |
| hydrogen peroxide | increases phosphorylation | ISO | RGD:736023 | 6480464 | Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:15795422 PMID:20302854 |
| hydrogen peroxide | multiple interactions | ISO | RGD:736023 | 6480464 | Mycophenolic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20302854 |
| hydrogen peroxide | increases phosphorylation | EXP | | 6480464 | Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:19345205 |
| hydrogen peroxide | increases activity | EXP | | 6480464 | Hydrogen Peroxide results in increased activity of MAPK9 protein | CTD | PMID:15574683 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | AG 1879 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK9 protein]; more ... | CTD | PMID:15574683 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | 2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:19345205 |
| hydrogen peroxide | increases activity | ISO | RGD:736024 | 6480464 | Hydrogen Peroxide results in increased activity of MAPK9 protein | CTD | PMID:11181820 |
| hydrogen peroxide | multiple interactions | ISO | RGD:736023 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15795422 |
| hydrogen peroxide | increases phosphorylation | ISO | RGD:736023 | 6480464 | Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:15795422 |
| hypochlorous acid | multiple interactions | ISO | RGD:736023 | 6480464 | Hypochlorous Acid results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:18156441 |
| iomeprol | increases phosphorylation | ISO | RGD:736023 | 6480464 | iomeprol results in increased phosphorylation of MAPK9 protein | CTD | PMID:21036957 |
| L-ascorbic acid | multiple interactions | ISO | RGD:736023 | 6480464 | Ascorbic Acid inhibits the reaction [Plant Extracts results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20206247 |
| L-cysteine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Cysteine deficiency] results in increased activity of MAPK9 protein | CTD | PMID:11709198 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Cysteine deficiency] results in increased activity of MAPK9 protein | CTD | PMID:11709198 |
| L-methionine | multiple interactions | ISO | RGD:736024 | 6480464 | Tamoxifen inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:23038002 |
| L-methionine | multiple interactions | ISO | RGD:736024 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAPK9 gene | CTD | PMID:20938992 |
| lead diacetate | multiple interactions | ISO | RGD:736023 | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA | CTD | PMID:12634122 |
| lead diacetate | multiple interactions | EXP | | 6480464 | [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein; more ... | CTD | PMID:20829427 |
| lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of MAPK9 protein | CTD | PMID:18296634 |
| luteolin | increases phosphorylation | ISO | RGD:736023 | 6480464 | Luteolin results in increased phosphorylation of MAPK9 protein | CTD | PMID:21601631 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:16018989 |
| manganese atom | increases phosphorylation | ISO | RGD:736023 | 6480464 | Manganese results in increased phosphorylation of MAPK9 protein | CTD | PMID:17045426 |
| manganese atom | multiple interactions | ISO | RGD:736023 | 6480464 | Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22561169 |
| manganese atom | increases phosphorylation | ISO | RGD:736023 | 6480464 | Manganese results in increased phosphorylation of MAPK9 protein | CTD | PMID:17045426 PMID:22561169 |
| manganese(0) | increases phosphorylation | ISO | RGD:736023 | 6480464 | Manganese results in increased phosphorylation of MAPK9 protein | CTD | PMID:17045426 |
| manganese(0) | multiple interactions | ISO | RGD:736023 | 6480464 | Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22561169 |
| manganese(0) | increases phosphorylation | ISO | RGD:736023 | 6480464 | Manganese results in increased phosphorylation of MAPK9 protein | CTD | PMID:17045426 PMID:22561169 |
| manganese(II) chloride | increases activity | ISO | RGD:736023 | 6480464 | manganese chloride results in increased activity of MAPK9 protein | CTD | PMID:20152896 |
| manganese(II) chloride | increases phosphorylation | ISO | RGD:736023 | 6480464 | manganese chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:19084589 PMID:20152896 |
| manganese(II) chloride | increases phosphorylation | ISO | RGD:736023 | 6480464 | manganese chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:20152896 PMID:19084589 |
| mangiferin | decreases expression | ISO | RGD:736024 | 6480464 | mangiferin results in decreased expression of MAPK9 mRNA | CTD | PMID:15135318 |
| mebendazole | increases phosphorylation | ISO | RGD:736023 | 6480464 | Mebendazole results in increased phosphorylation of MAPK9 protein | CTD | PMID:20848085 |
| melatonin | increases expression | ISO | RGD:736023 | 6480464 | Melatonin results in increased expression of MAPK9 protein | CTD | PMID:19012662 |
| metformin | multiple interactions | ISO | RGD:736023 | 6480464 | Metformin inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK9 protein] | CTD | PMID:16385087 |
| methotrexate | increases phosphorylation | EXP | | 6480464 | Methotrexate results in increased phosphorylation of MAPK9 protein | CTD | PMID:20885979 |
| microcystin-LR | increases expression | ISO | RGD:736024 | 6480464 | cyanoginosin LR results in increased expression of MAPK9 mRNA | CTD | PMID:17654400 |
| mycophenolic acid | multiple interactions | ISO | RGD:736023 | 6480464 | Mycophenolic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20302854 |
| mycophenolic acid | decreases expression | EXP | | 6480464 | Mycophenolic Acid results in decreased expression of MAPK9 protein modified form | CTD | PMID:20302854 |
| myricetin | multiple interactions | ISO | RGD:736024 | 6480464 | myricetin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:17693661 |
| N(6),N(6)-dimethyladenine | multiple interactions | EXP | | 6480464 | N(6),N(6)-dimethyladenine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:15618353 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:736024 | 6480464 | Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:14687664 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:736023 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:18412143 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19760616 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22085843 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21145380 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:736024 | 6480464 | Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19654923 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:736023 | 6480464 | Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21391979 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:736023 | 6480464 | Acetylcysteine inhibits the reaction [advanced glycation end products-bovine serum albumin results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:19553346 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:736023 | 6480464 | Acetylcysteine inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21135414 |
| N-methyl-4-phenylpyridinium | increases activity | ISO | RGD:736024 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased activity of MAPK9 protein | CTD | PMID:11181820 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:736023 | 6480464 | Methylnitronitrosoguanidine results in increased expression of MAPK9 mRNA | CTD | PMID:12634122 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPK9 mRNA | CTD | PMID:17602206 |
| N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | Dimethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:12971962 |
| nickel dichloride | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [nickel chloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21843586 |
| nickel dichloride | increases phosphorylation | EXP | | 6480464 | nickel chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:21843586 |
| nickel sulfate | increases phosphorylation | ISO | RGD:736023 | 6480464 | nickel sulfate results in increased phosphorylation of MAPK9 protein | CTD | PMID:15588916 |
| nickel sulfate | increases phosphorylation | ISO | RGD:736023 | 6480464 | nickel sulfate results in increased phosphorylation of MAPK9 protein | CTD | PMID:15588916 PMID:19101624 |
| nimesulide | decreases phosphorylation | ISO | RGD:736023 | 6480464 | nimesulide results in decreased phosphorylation of MAPK9 protein | CTD | PMID:15825163 |
| nitroprusside | multiple interactions | ISO | RGD:736023 | 6480464 | Nitroprusside inhibits the reaction [advanced glycation end products-bovine serum albumin results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:19553346 |
| nitroprusside | decreases expression | EXP | | 6480464 | Nitroprusside results in decreased expression of MAPK9 protein modified form | CTD | PMID:20132804 |
| nocodazole | increases phosphorylation | ISO | RGD:736023 | 6480464 | Nocodazole results in increased phosphorylation of MAPK9 protein | CTD | PMID:12221076 |
| nocodazole | multiple interactions | ISO | RGD:736023 | 6480464 | TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of MAPK9 protein] | CTD | PMID:12221076 |
| NS-398 | decreases phosphorylation | ISO | RGD:736023 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased phosphorylation of MAPK9 protein | CTD | PMID:15825163 |
| ozone | increases phosphorylation | ISO | RGD:736023 | 6480464 | Ozone results in increased phosphorylation of MAPK9 protein | CTD | PMID:19536146 |
| paclitaxel | multiple interactions | ISO | RGD:736023 | 6480464 | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19944065 |
| paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel analog results in increased expression of MAPK9 mRNA | CTD | PMID:15585946 |
| paclitaxel | increases expression | ISO | RGD:736023 | 6480464 | Paclitaxel results in increased expression of MAPK9 protein | CTD | PMID:16051289 |
| paclitaxel | multiple interactions | ISO | RGD:736023 | 6480464 | [esculetin co-treated with Paclitaxel] results in increased expression of MAPK9 protein | CTD | PMID:16051289 |
| palmitic acid | multiple interactions | ISO | RGD:736023 | 6480464 | Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21745629 |
| palmitic acid | increases phosphorylation | ISO | RGD:736023 | 6480464 | Palmitic Acid results in increased phosphorylation of MAPK9 protein | CTD | PMID:21745629 |
| paracetamol | multiple interactions | ISO | RGD:736024 | 6480464 | manumycin inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:19739265 |
| paracetamol | multiple interactions | ISO | RGD:736024 | 6480464 | Glutathione inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:20423716 |
| paracetamol | multiple interactions | ISO | RGD:736024 | 6480464 | IL4 gene mutant form promotes the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22107450 |
| paracetamol | increases phosphorylation | ISO | RGD:736024 | 6480464 | Acetaminophen results in increased phosphorylation of MAPK9 protein | CTD | PMID:19931551 more ... |
| paracetamol | increases expression | ISO | RGD:736023 | 6480464 | Acetaminophen results in increased expression of MAPK9 mRNA | CTD | PMID:21420995 |
| paracetamol | multiple interactions | ISO | RGD:736024 | 6480464 | Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:19739265 PMID:18700144 |
| paracetamol | decreases response to substance | ISO | RGD:736024 | 6480464 | MAPK9 results in decreased susceptibility to Acetaminophen | CTD | PMID:18586006 |
| paracetamol | increases response to substance | ISO | RGD:736024 | 6480464 | MAPK9 protein results in increased susceptibility to Acetaminophen | CTD | PMID:18700144 |
| paracetamol | multiple interactions | ISO | RGD:736024 | 6480464 | MAP3K5 protein promotes the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:18700144 |
| paracetamol | increases phosphorylation | ISO | RGD:736024 | 6480464 | Acetaminophen results in increased phosphorylation of MAPK9 protein | CTD | PMID:20363829 |
| paracetamol | multiple interactions | ISO | RGD:736024 | 6480464 | Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:18700144 PMID:19739265 |
| paraquat | multiple interactions | ISO | RGD:736023 | 6480464 | Paraquat results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:17018646 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of MAPK9 mRNA | CTD | PMID:18198484 |
| paraquat | increases phosphorylation | EXP | | 6480464 | Paraquat results in increased phosphorylation of MAPK9 protein | CTD | PMID:16687388 |
| paraquat | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Paraquat results in increased phosphorylation of MAPK9 protein] | CTD | PMID:16687388 |
| phenylephrine | multiple interactions | ISO | RGD:736024 | 6480464 | MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Phenylephrine] | CTD | PMID:16949803 |
| phenylephrine | increases phosphorylation | EXP | | 6480464 | Phenylephrine results in increased phosphorylation of MAPK9 protein | CTD | PMID:10727428 |
| phenylephrine | affects response to substance | ISO | RGD:736024 | 6480464 | MAPK9 protein affects the susceptibility to Phenylephrine | CTD | PMID:16949803 |
| phlorizin | decreases expression | ISO | RGD:736024 | 6480464 | Phlorhizin results in decreased expression of MAPK9 mRNA | CTD | PMID:22538082 |
| phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | RGD:736023 | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein | CTD | PMID:16838270 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:736023 | 6480464 | pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19447859 |
| phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | RGD:736023 | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein | CTD | PMID:16838270 more ... |
| phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | RGD:736023 | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein | CTD | PMID:16838270 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:736023 | 6480464 | Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22561169 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:736023 | 6480464 | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20599481 |
| phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | RGD:736023 | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein | CTD | PMID:16838270 more ... |
| phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | RGD:736024 | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein | CTD | PMID:17693661 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:736024 | 6480464 | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:17693661 |
| phorone | multiple interactions | ISO | RGD:736024 | 6480464 | [phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein | CTD | PMID:20423716 |
| potassium chloride | multiple interactions | ISO | RGD:736024 | 6480464 | MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Potassium Chloride] | CTD | PMID:16949803 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of MAPK9 mRNA | CTD | PMID:19162173 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of MAPK9 mRNA | CTD | PMID:17170212 |
| pterostilbene | multiple interactions | ISO | RGD:736023 | 6480464 | pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19447859 |
| quercetin | multiple interactions | ISO | RGD:736023 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15795422 |
| resveratrol | increases activity | ISO | RGD:736024 | 6480464 | resveratrol results in increased activity of MAPK9 protein | CTD | PMID:11933078 |
| resveratrol | multiple interactions | ISO | RGD:736023 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [resveratrol results in increased phosphorylation of MAPK9 protein] | CTD | PMID:18347188 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MAPK9 mRNA | CTD | PMID:19228061 |
| resveratrol | increases phosphorylation | ISO | RGD:736023 | 6480464 | resveratrol results in increased phosphorylation of MAPK9 protein | CTD | PMID:18347188 |
| resveratrol | multiple interactions | ISO | RGD:736024 | 6480464 | resveratrol inhibits the reaction [Excitatory Amino Acid Agents results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:20542495 |
| resveratrol | multiple interactions | ISO | RGD:736023 | 6480464 | resveratrol results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:18222423 |
| resveratrol | multiple interactions | ISO | RGD:736024 | 6480464 | [resveratrol results in increased activity of MAPK9 protein] which results in increased phosphorylation of and results in increased activity of TRP53 protein | CTD | PMID:11933078 |
| Ro 31-8220 | multiple interactions | EXP | | 6480464 | Ro 31-8220 inhibits the reaction [Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK9 protein] | CTD | PMID:11756236 |
| rotenone | increases activity | ISO | RGD:736024 | 6480464 | Rotenone results in increased activity of MAPK9 protein | CTD | PMID:11181820 |
| sanguinarine | multiple interactions | ISO | RGD:736023 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [sanguinarine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19135517 |
| sanguinarine | increases phosphorylation | ISO | RGD:736023 | 6480464 | sanguinarine results in increased phosphorylation of MAPK9 protein | CTD | PMID:19135517 |
| selenium atom | multiple interactions | ISO | RGD:736023 | 6480464 | [Selenium co-treated with SB 203580] results in decreased expression of MAPK9 protein | CTD | PMID:18583539 |
| selenium atom | decreases expression | ISO | RGD:736023 | 6480464 | Selenium results in decreased expression of MAPK9 protein modified form | CTD | PMID:18583539 |
| silibinin | increases phosphorylation | ISO | RGD:736023 | 6480464 | silybin results in increased phosphorylation of MAPK9 protein | CTD | PMID:16777994 |
| silibinin | multiple interactions | ISO | RGD:736023 | 6480464 | pifithrin inhibits the reaction [silybin results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:16777994 |
| simvastatin | increases activity | ISO | RGD:736024 | 6480464 | Simvastatin results in increased activity of MAPK9 protein | CTD | PMID:15187114 |
| sodium dichromate | multiple interactions | ISO | RGD:736024 | 6480464 | MAPK9 protein affects the reaction [sodium bichromate results in increased cleavage of BID protein]; more ... | CTD | PMID:21047991 |
| sodium dichromate | affects response to substance | ISO | RGD:736024 | 6480464 | MAPK9 protein affects the susceptibility to sodium bichromate | CTD | PMID:21047991 |
| streptozocin | multiple interactions | EXP | | 6480464 | chromium mesoporphyrin inhibits the reaction [Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA]] | CTD | PMID:19190261 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of MAPK9 mRNA | CTD | PMID:19190261 |
| sulfasalazine | increases phosphorylation | EXP | | 6480464 | Sulfasalazine results in increased phosphorylation of MAPK9 protein | CTD | PMID:15633128 |
| sulforaphane | increases phosphorylation | ISO | RGD:736023 | 6480464 | sulforafan results in increased phosphorylation of MAPK9 protein | CTD | PMID:16033772 |
| tamoxifen | affects expression | ISO | RGD:736023 | 6480464 | Tamoxifen affects the expression of MAPK9 mRNA | CTD | PMID:14699072 |
| tamoxifen | multiple interactions | ISO | RGD:736024 | 6480464 | Tamoxifen inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:23038002 |
| taurine | multiple interactions | ISO | RGD:736023 | 6480464 | Taurine inhibits the reaction [advanced glycation end products-bovine serum albumin results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:19553346 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:736024 | 6480464 | [phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein | CTD | PMID:20423716 |
| tetracaine | multiple interactions | EXP | | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:11981161 |
| tetracaine | increases phosphorylation | EXP | | 6480464 | Tetracaine results in increased phosphorylation of MAPK9 protein | CTD | PMID:11981161 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MAPK9 protein | CTD | PMID:18081878 |
| tetrachloromethane | increases phosphorylation | ISO | RGD:736024 | 6480464 | Carbon Tetrachloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:21291945 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of MAPK9 mRNA | CTD | PMID:16239168 |
| thapsigargin | increases phosphorylation | EXP | | 6480464 | Thapsigargin results in increased phosphorylation of MAPK9 protein | CTD | PMID:21147958 |
| thimerosal | increases phosphorylation | ISO | RGD:736023 | 6480464 | Thimerosal results in increased phosphorylation of MAPK9 protein | CTD | PMID:17698513 |
| trans-resveratrol | increases activity | ISO | RGD:736024 | 6480464 | resveratrol results in increased activity of MAPK9 protein | CTD | PMID:11933078 |
| trans-resveratrol | multiple interactions | ISO | RGD:736023 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [resveratrol results in increased phosphorylation of MAPK9 protein] | CTD | PMID:18347188 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MAPK9 mRNA | CTD | PMID:19228061 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:736023 | 6480464 | resveratrol results in increased phosphorylation of MAPK9 protein | CTD | PMID:18347188 |
| trans-resveratrol | multiple interactions | ISO | RGD:736024 | 6480464 | resveratrol inhibits the reaction [Excitatory Amino Acid Agents results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:20542495 |
| trans-resveratrol | multiple interactions | ISO | RGD:736023 | 6480464 | resveratrol results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:18222423 |
| trans-resveratrol | multiple interactions | ISO | RGD:736024 | 6480464 | [resveratrol results in increased activity of MAPK9 protein] which results in increased phosphorylation of and results in increased activity of TRP53 protein | CTD | PMID:11933078 |
| trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of MAPK9 mRNA | CTD | PMID:19448997 |
| trichostatin A | multiple interactions | ISO | RGD:736023 | 6480464 | trichostatin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; more ... | CTD | PMID:21911040 |
| triclosan | multiple interactions | ISO | RGD:736023 | 6480464 | Triclosan inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:19874453 |
| trifluoperazine | multiple interactions | ISO | RGD:736023 | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
| trifluoperazine | multiple interactions | ISO | RGD:736024 | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
| trifluoperazine | multiple interactions | EXP | | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
| tunicamycin | increases phosphorylation | EXP | | 6480464 | Tunicamycin results in increased phosphorylation of MAPK9 protein | CTD | PMID:21147958 |
| vincaleukoblastine | multiple interactions | ISO | RGD:736023 | 6480464 | TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:12221076 |
| vincaleukoblastine | increases phosphorylation | ISO | RGD:736023 | 6480464 | Vinblastine results in increased phosphorylation of MAPK9 protein | CTD | PMID:12221076 |
| zinc dichloride | multiple interactions | ISO | RGD:736024 | 6480464 | zinc chloride inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20423716 |